Percheron Therapeutics (AU:PER) has released an update.
Platinum Investment Management Limited has increased its substantial shareholding in Percheron Therapeutics Limited, now holding 9.57% of the company’s ordinary shares. This move by Platinum Asset Management could signal growing confidence in Percheron’s future prospects, sparking interest among investors in the pharmaceutical sector.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.